Fever in the ICU

advertisement

Cardiac Arrhythmias in the SICU

Charles Hobson, MD MHA

Surgical Critical Care

NFSG VA Medical Center

Objectives

Review the etiology and recognition of common arrhythmias seen in the SICU.

Review management of cardiac arrhythmias, with a focus on the relevant recent literature.

Normal Sinus Rhythm

www.uptodate.com

Implies normal sequence of conduction, originating in the sinus node and proceeding to the ventricles via the AV node and His-Purkinje system.

EKG Characteristics: Regular narrow-complex rhythm

Rate 60-100 bpm

Each QRS complex is proceeded by a P wave

P wave is upright in lead II & downgoing in lead aVR

Mechanisms of Arrhythmias

Automaticity or

Ectopic Foci

Reentry / Conduction Block

Decreased Automaticity

Sinus Bradycardia

www.uptodate.com

Increased/Abnormal Automaticity

www.uptodate.com

Sinus tachycardia

Ectopic atrial tachycardia

Junctional tachycardia

Ectopic Foci and Beats

Atrial Escape Beats

QRS is slightly different but still narrow , indicating that conduction through the ventricle is relatively normal normal ("sinus") beats sinus node doesn't fire leading to a period of asystole (sick sinus syndrome) p-wave has different shape indicating it did not originate in the sinus node, but somewhere in the atria.

Ectopic Foci and Beats

Paroxysmal Supraventricular Tachycardia (PSVT)

• A single ectopic focus fires near the AV node, which then conducts normally to the ventricles (usually initiated by a PAC)

•The rhythm is always REGULAR

•Prolonged runs of PSVT may result in atrial fibrillation or atrial flutter

• May be terminated by carotid massage

• Treatment: carotid massage, adenosine, Ca ++ channel blockers, ablation

•Adenosine preferred in hypotension, previous IV B-blocker

Rhythm usually begins with PAC

Note REGULAR rhythm in the tachycardia

Ectopic Foci and Beats

Multifocal Atrial Tachycardia (MAT)

•Multiple ectopic foci fire in the atria, all of which are conducted normally to the ventricles

•The rhythm is always IRREGULAR

• P-waves of different morphologies (shapes) may be seen

•Commonly seen in pulmonary disease, acute cardiorespiratory problems, and CHF

• Treatment:

• Ca++ channel blockers, beta blockers, but antiarrhythmic drugs are often ineffective

• potassium, magnesium (McCord et al, Chest 1998) ,

Note IRREGULAR rhythm in the tachycardia

Junctional

Escape Beats

Ectopic Foci and Beats

QRS is slightly different but still narrow , indicating that conduction through the ventricle is relatively normal there is no p wave , indicating that it did not originate anywhere in the atria, but since the QRS complex is still thin and normal looking, we can conclude that the beat originated somewhere near the AV junction.

Ectopic Foci and Beats

Ventricular

Escape Beats

“PVCs”

QRS is wide and much different looking than the normal beats. This indicates that the beat originated somewhere in the ventricles.

•no p wave , indicating that the beat did not originate anywhere in the atria

•a "retrograde” p-wave may sometimes be seen on the right hand side of beats that originate in the ventricles, indicating that depolarization has spread back up through the atria from the ventricles

PVC's are Dangerous When:

•They are frequent (> 30% of complexes) or are increasing in frequency

• The come close to or on top of a preceding T-wave ( R on T )

• Three or more PVC's in a row (run of V-tach )

• Any PVC in the setting of an acute MI

• PVC's come from different foci (" multifocal " or "multiformed")

These may result in ventricular tachycardia or fibrillation.

“R on T phenomenon” time

Unconverted V-tach to V-fib sinus beats V-tach

Causes of Ectopic Foci and Beats

• hypoxic myocardium - chronic pulmonary disease, pulmonary embolus

• ischemic myocardium - acute MI, expanding MI, angina

• sympathetic stimulation - nervousness, exercise, CHF, hyperthyroidism

• drugs & electrolyte imbalances - antiarrhythmic drugs, hypokalemia, imbalances of calcium and magnesium

• bradycardia - a slow HR predisposes one to arrhythmias

• enlargement of the atria or ventricles producing stretch in pacemaker cells

The Reentry Mechanism of Ectopic Beats & Rhythms

Electrical Impulse

Cardiac

Conduction

Tissue

Fast Conduction Path

Slow Recovery

Slow Conduction Path

Fast Recovery

Tissues with these type of circuits may exist:

• in the SA node, AV node, or any type of heart tissue

• in a “macroscopic” structure such as an accessory pathway in WPW

The Reentry Mechanism of Ectopic Beats & Rhythms

Premature Beat Impulse

Repolarizing Tissue

(long refractory period)

Cardiac

Conduction

Tissue

Fast Conduction Path

Slow Recovery

Slow Conduction Path

Fast Recovery

1. An arrhythmia is triggered by a premature beat

2. The beat cannot gain entry into the fast conducting pathway because of its long refractory period and therefore travels down the slow conducting pathway only

The Reentry Mechanism of Ectopic Beats & Rhythms

Fast Conduction Path

Slow Recovery

Cardiac

Conduction

Tissue

Slow Conduction Path

Fast Recovery

3. The wave of excitation from the premature beat arrives at the distal end of the fast conducting pathway, which has now recovered and therefore travels retrograde

(backwards) up the fast pathway

The Reentry Mechanism of Ectopic Beats & Rhythms

Fast Conduction Path

Slow Recovery

Cardiac

Conduction

Tissue

Slow Conduction Path

Fast Recovery

4. On arriving at the top of the fast pathway it finds the slow pathway has recovered and therefore the wave of excitation ‘reenters’ the pathway and continues in a ‘circular’ movement.

This creates the re-entry circuit

Reentrant Rhythms

AV nodal reentrant tachycardia (AVNRT)

– Supraventricular tachycardia

AV reentrant tachycardia (AVRT)

– Wolf – Parkinson – White syndrome

Atrial flutter

Ventricular tachycardia

Atrial fibrillation

Ventricular fibrillation

Reentry Circuits as Ectopic Foci and Arrhythmia Generators

Atrial Re-entry

• atrial tachycardia

• atrial fibrillation

• atrial flutter

Atrio-Ventricular Nodal Re-entry

• supraventricular tachycardia

Ventricular Re-entry

• ventricular tachycardia

•ventricular fibrillation

Atrio-Ventricular Re-entry

• Wolf Parkinson White

• supraventricular tachycardia

AV Nodal Reentrant Tachycardia

Rate 100-270

Normal QRS

Aberrancy possible

Acute Rx:

•Vagal maneuvers

•Adenosine 6-12 mg IV push – beware of pro-arrhythmia

•Ca++ channel blockers

Atrial Flutter

www.uptodate.com

Atrial flutter is caused by a reentrant circuit in the wall of the atrium

EKG Characteristics: Typical: “sawtooth” flutter waves at a rate of ~ 300 bpm

Flutter waves have constant amplitude, duration, and morphology through the cardiac cycle

There is usually either a 2:1 or 4:1 block at the AV node, resulting in ventricular rates of either 150 or 75 bpm

Dx and Rx of Flutter

Unmasking of flutter waves with adenosine.

Acute Rx:

•ventricular rate control can be difficult

•AV nodal blockers prevent 1:1 conduction

•Ibutilide 1-2mg rapid IV infusion – have paddles ready

•Rapid pacing or low voltage DC cardioversion is effective

•Anticoagulation as per atrial fibrillation

Ventricular Tachycardia

Rate 100-20

Wide QRS

Monomorphic vs

Polymorphic

Beware:

•Accelerated idioventricular rhythm. Rate below 150, stable hemodynamics, benign prognosis.

•SVT with aberrancy. Look at the 12 lead – not just a rhythm strip

•Monomorphic vs. Polymorphic (long QT, bradycardia, ischemia )

Rx:

•Unstable – DC cardioversion

•Stable monomorphic – Procainamide, Amiodarone

•Stable polymorphic - treat underlying etiology

Atrial Fibrillation

www.uptodate.com

Atrial fibrillation is caused by numerous waves of depolarization spreading throughout the atria , leading to an absence of coordinated atrial contraction.

Classified as:

Recurrent: when AF occurs on 2 or more occasions

Paroxysmal: episodes that generally last </= 7 days (most last <24h)

Persistent: AF that last >/=7 days

Permanent: paroxysmal or persistent AF with failure to cardiovert or not attempted

Dx and Rx of Atrial Fibrillation

Absent P waves

Irregularly irregular ventricular response

Acute Rx:

•rate control not rhythm control – AFFIRM trial (NEJM 2002):

B-blockers, Ca++ channel blockers, digoxin, amiodarone

•Ibutilide 1-2mg rapid IV infusion – have paddles ready

•Oral propafenone or flecainide – beware pro-arrhythmia

•Low voltage DC cardioversion

•Anticoagulation as per atrial fibrillation

On the horizon: vernakalant , an atrial-selective Na and K channel blocker for conversion of short-duration atrial fibrillation

Ventricular Fibrillation

www.uptodate.com

Ventricular fibrillation is caused by numerous waves of depolarization spreading throughout the ventricles simultaneously, leading to disorganized ventricular contraction and immediate loss of cardiac function.

EKG Characteristics: Absent P waves

Disorganized electrical activity

Deflections continuously change in shape, magnitude and direction

Rhythms Produced by Conduction Block

AV Block (relatively common)

– 1 st degree AV block

– Type 1 2 nd degree AV block

– Type 2 2 nd degree AV block

– 3 rd degree AV block

SA Block (relatively rare)

1

st

Degree AV Block

EKG Characteristics:

The Alan E. Lindsay ECG Learning Center ; http://medstat.med.utah.edu/kw/ecg/

Prolongation of the PR interval, which is constant

All P waves are conducted

Usually benign

2

nd

Degree AV Block

Mobitz 1

(Wenckebach)

EKG Characteristics: Progressive prolongation of the PR interval until a P wave is not conducted.

As the PR interval prolongs, the RR interval actually shortens

Usually benign unless associated with underlying pathology, i.e. MI

2

nd

Degree AV Block

Mobitz 2

EKG Characteristics: Constant PR interval with intermittent failure to conduct

• Rhythm is dangerous as the block is lower in the conduction system

• May cause syncope or may deteriorate into complete heart block

•Causes: anterioseptal MI, fibrotic disease of the conduction system

• Treatment: may require pacemaker in the case of fibrotic conduction system

3

rd

Degree (Complete) AV Block

EKG Characteristics: No relationship between P waves and QRS complexes

Constant PP intervals and RR intervals

• May be caused by inferior MI and it’s presence worsens the prognosis

• May cause syncopal symptoms, angina, or CFH

•Treatment: usually requires pacemaker

Right Bundle Branch Block (RBBB)

1.

Depolarization spreads from the left ventricle to the right ventricle.

2.

This creates a second Rwave (R’) in V1 , and a slurred S-wave in V5 - V6 .

3.

The T wave should be deflected opposite the terminal deflection of the QRS complex.

This is known as appropriate T wave discordance with bundle branch block. A concordant T wave may suggest ischemia or myocardial infarction.

Left Bundle Branch Block (LBBB)

1.

Depolarization enters the right side of the right ventricle first and simultaneously depolarizes the septum from right to left.

2.

This creates a QS or rS complex in lead V1 and a monophasic or notched R wave in lead V6 .

3.

The T wave should be deflected opposite the terminal deflection of the QRS complex. This is known as appropriate T wave discordance with bundle branch block. A concordant T wave may suggest ischemia or myocardial infarction.

Antiarrhythmia Agents

Class 1A agents: Procainamide, quinidine

Uses

Wide spectrum, but side effects limit usage

Quinidine : maintain sinus rhythms in atrial fibrillation and flutter and to prevent recurrent tachycardia and fibrillation

Procainamide: acute treatment of supraventricular and ventricular arrhythmias (no longer in production)

Side effects

Hypotension, reduced cardiac output

Proarrhythmia (generation of a new arrhythmia) eg.

Torsades de Points (  QT interval)

Dizziness, confusion, insomnia, seizure (high dose)

Gastrointestinal effects (common)

Lupus-like syndrome (esp. procainamide )

Class 1B agents: Lidocaine , phenytoin

Uses acute : Ventricular tachycardia and fibrillation (esp. during ischemia)

Not used in atrial arrhythmias or AV junctional arrhythmias

Side effects

Less proarrhythmic than Class 1A (less QT effect)

CNS effects: dizziness, drowsiness

Class 1C agents: Flecainide , propafenone

Uses

Wide spectrum

Used for supraventricular arrhythmias (fibrillation and flutter)

Premature ventricular contractions (caused problems)

Wolff-Parkenson-White syndrome

Side effects

Proarrhythmia and sudden death especially with chronic use (CAST study)

Increase ventricular response to supraventricular arrhythmias

CNS and gastrointestinal effects like other local anesthetics

Class II agents: Propranolol, esmolol

Uses treating sinus and catecholamine dependent tachy arrhythmias converting reentrant arrhythmias in AV protecting the ventricles from high atrial rates (slow AV conduction)

Side effects bronchospasm hypotension beware in partial AV block or ventricular failure

Class III agents: Amiodarone, sotalol, ibutilide

Amiodarone

Uses

Very wide spectrum: effective for most arrhythmias

Side effects: many serious that increase with time

Pulmonary fibrosis

Hepatic injury

Increase LDL cholesterol

Thyroid disease

Photosensitivity

May need to reduce the dose of digoxin and class 1 antiarrhythmics

Class III agents: Amiodarone, sotalol, ibutilide

Sotalol

Uses

Wide spectrum: supraventricular and ventricular tachycardia

Side effects

Proarrhythmia, fatigue, insomnia

Class III agents: Amiodarone, sotalol, ibutilide

Ibutilide

Uses conversion of atrial fibrillation and flutter with rapid IV infusion

Side effects

Torsades de pointes

Class IV agents: Verapamil and diltiazem

Uses control ventricular rate during supraventricular tachycardia convert supraventricular tachycardia (re-entry around AV)

Side effects

Caution when partial AV block is present.

Can get asystole if β blocker is on board

Caution when hypotension, decreased CO or sick sinus

Some gastrointestinal problems

Additional agents

Adenosine

Administration rapid i.v. bolus, very short T1/2 (seconds)

Cardiac effects

Slows AV conduction

Uses convert re-entrant supraventricular arrhythmias hypotension during surgery, diagnosis of CAD

Magnesium treatment for tachycardia resulting from long QT

Additional agents

Digoxin (cardiac glycosides)

Mechanism enhances vagal activity, inhibits Na/K ATPase

 refractory period, slows AV conduction

Uses treatment of atrial fibrillation and flutter

Atropine

Mechanism selective muscarinic antagonist

Cardiac effects blocks vagal activity to speed AV conduction and increase HR

Uses treat vagal bradycardia

Selected References:

ACC/AHA/ESC Practice Guidelines:

 Supraventricular Arrhythmias – JACC 2003;42:1993-531.

 Atrial Fibrillation – JACC 2006;48:854-906

 Ventricular Arrhythmias – JACC 2006;48:1064-1108

Thanks, and questions?

Download